Merus N.V. (MRUS) Acquired by Genmab in $6.9 Billion Deal, Announces Leadership Changes
Merus N.V. (MRUS) completed its acquisition by Genmab A/S for $6.9 billion, resulting in a change of control and new executive appointments.
$MRUS
Merus N.V. (MRUS) Acquired by Genmab for $6.9 Billion, Completes Change in Control
Merus N.V. (MRUS) completed its acquisition by Genmab A/S for approximately $6.9 billion, resulting in a change in control and leadership changes.